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Abstract
© 2017 N. S. Zakharchenko et al. Previously transgenic Kalanchoe pinnata plants producing an
antimicrobial peptide cecropin P1 (CecP1) have been reported. Now we report biological testing
K. pinnata extracts containing CecP1 as a candidate drug for treatment of wounds infected with
Candida albicans. The drug constitutes the whole juice from K. pinnata leaves (not ethanol
extract) sterilized with nanofiltration. A microbicide activity of CecP1 against an animal fungal
pathogen in vivo was demonstrated for the first time. However, a favorable therapeutic effect of
the transgenic K. pinnata extract was attributed to a synergism between the fungicide activity of
CecP1 and wound healing (antiscar), revascularizing, and immunomodulating effect of natural
biologically active components of K. pinnata. A commercial fungicide preparation clotrimazole
eliminated C. albicans cells within infected wounds in rats with efficiency comparable to CecP1-
enriched K. pinnata extract. But in contrast to K. pinnata extract, clotrimazole did not exhibit
neither wound healing activity nor remodeling of the scar matrix. Taken together, our results
allow assumption that CecP1-enriched K. pinnata extracts should be considered as a candidate
drug for treatment of dermatomycoses, wounds infected with fungi, and bedsores.
http://dx.doi.org/10.1155/2017/3940743
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